Bridge Biotherapeutics (Korea) Analysis
| 288330 Stock | KRW 4,050 445.00 9.90% |
Bridge Biotherapeutics is overvalued with Real Value of 3488.1 and Hype Value of 4050.0. The main objective of Bridge Biotherapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Bridge Biotherapeutics is worth, separate from its market price. There are two main types of Bridge Biotherapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bridge Biotherapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bridge Biotherapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Bridge Biotherapeutics stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bridge Biotherapeutics' ongoing operational relationships across important fundamental and technical indicators.
Bridge |
Bridge Stock Analysis Notes
About 30.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Bridge Biotherapeutics had 1:1 split on the 29th of July 2024. Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. The company was founded in 2015 and is headquartered in Seongnam, Korea. BRIDGE BIOTHERAPEUTICS is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Bridge Biotherapeutics go to http://bridgebiorx.com.Bridge Biotherapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bridge Biotherapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bridge Biotherapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Bridge Biotherapeutics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 1.92 B. Net Loss for the year was (26.28 B) with loss before overhead, payroll, taxes, and interest of (1.12 B). | |
| Bridge Biotherapeutics has accumulated about 8.2 B in cash with (21.13 B) of positive cash flow from operations. | |
| Roughly 30.0% of the company shares are owned by insiders or employees |
Bridge Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 217.07 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bridge Biotherapeutics's market, we take the total number of its shares issued and multiply it by Bridge Biotherapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 25th of December, Bridge Biotherapeutics shows the Downside Deviation of 6.24, mean deviation of 6.07, and Risk Adjusted Performance of 0.037. Bridge Biotherapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bridge Biotherapeutics Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bridge Biotherapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bridge Biotherapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Bridge Biotherapeutics Predictive Daily Indicators
Bridge Biotherapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bridge Biotherapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.12 | |||
| Daily Balance Of Power | (0.78) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 4285.0 | |||
| Day Typical Price | 4206.67 | |||
| Market Facilitation Index | 570.0 | |||
| Price Action Indicator | (457.50) | |||
| Period Momentum Indicator | (445.00) |
Bridge Biotherapeutics Forecast Models
Bridge Biotherapeutics' time-series forecasting models are one of many Bridge Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bridge Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bridge Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bridge Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bridge shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bridge Biotherapeutics. By using and applying Bridge Stock analysis, traders can create a robust methodology for identifying Bridge entry and exit points for their positions.
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. The company was founded in 2015 and is headquartered in Seongnam, Korea. BRIDGE BIOTHERAPEUTICS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bridge Biotherapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Complementary Tools for Bridge Stock analysis
When running Bridge Biotherapeutics' price analysis, check to measure Bridge Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bridge Biotherapeutics is operating at the current time. Most of Bridge Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bridge Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bridge Biotherapeutics' price. Additionally, you may evaluate how the addition of Bridge Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |